Simple, per-trial pricing

Priced by the number of active patients per trial - not per seat or per API call. Annual billing saves 18% versus monthly.

Pilot

$1,490/mo

Single-site studies with up to 30 active patients. Ideal for Phase I dose-escalation or single-arm Phase II cohorts.

  • Up to 30 active patients
  • 1 trial protocol
  • Bayesian PK engine
  • HL7 FHIR R4 integration
  • 21 CFR Part 11 audit trail
  • Standard DOCX report output
  • Email support (48h response)
Get Started

Enterprise

Custom

Pharma sponsors running portfolios of trials across multiple CROs and investigational sites.

  • Unlimited patients and protocols
  • All Professional features
  • Population PK model sharing across sites
  • NONMEM/Phoenix import
  • Custom FHIR resource mapping
  • Dedicated validation package (GAMP 5)
  • On-site implementation support
  • Dedicated CSM + 2h SLA
Contact Sales

Annual billing saves 18%. All plans include a 30-day validation pilot at no charge. Prices in USD.

Common questions about pricing and setup

An active patient is any patient who has received at least one dose during the billing month and has not reached end-of-treatment or withdrawn consent. Patients in screening who have not yet received study drug do not count. Patients who complete treatment are archived and do not continue counting against your limit.

Protocol configuration takes 40-90 minutes for a standard two-compartment model. If your site uses LabVantage or STARLIMS, the LIMS connector is typically live within 3 business days. EDC integration via Medidata Rave or Veeva Vault takes 5-10 days depending on your EDC administrator's availability. Most sites are processing real patient data within two weeks of contract execution.

Professional plan includes standard IQ/OQ documentation. Enterprise plan includes a full GAMP 5 Category 4 validation package: Validation Plan, IQ, OQ, PQ test scripts and execution evidence, Requirements Traceability Matrix, and Risk Assessment. We will work with your CSV/QA team during the qualification phase. Additional site-specific PQ execution support is available as a professional services engagement.

Yes. You can switch to annual billing at any time and the 18% discount will be applied to the remaining contract period, prorated from the conversion date. Annual billing is invoiced upfront and is non-refundable for the committed period, but we have no multi-year lock-in requirements on standard plans.

DoseMind is a HIPAA Business Associate and will execute a BAA with each customer. Patient data is encrypted in transit (TLS 1.3) and at rest (AES-256). PHI de-identification is supported via HIPAA Safe Harbor workflow before any cross-site data sharing. We completed a SOC 2 Type II audit in Q4 2024 and a Synack Red Team penetration test in December 2024. Audit reports available under NDA.

Start with a validation pilot

We configure DoseMind for your protocol and run retrospective simulations on historical data at no charge before your first prospective patient is enrolled.

Talk to Sales